| 1 |
Notice for inviting comment to ensure a level playing field in new drug approval in India |
2025-Oct-08 |
|
597 KB |
| 2 |
Strict compliance with the Drugs Rules 1945 for testing of raw materials and finished formulations |
2025-Oct-07 |
|
418 KB |
| 3 |
Clarification for grant of permission for combipack product of lyophilised dry powder for injection /I.V infusion and diluents for reconstitution such as sterile water for injection / sodium Chloride Injection |
2025-Sep-29 |
|
301 KB |
| 4 |
ICMR-CDSCO Standard Performance Evaluation Protocols |
2025-Sep-17 |
|
7383 KB |
| 5 |
Separate provision for subsequent Importer in Online system for Medical Devices |
2025-Sep-15 |
|
477 KB |
| 6 |
Clarification for regulatory pathway for Cocrystals |
2025-Sep-15 |
|
546 KB |
| 7 |
Surrender of RC No. RC/COS-002850 valid upto 13'Dec-2026 issued to you for the purpose of import of cosmetics manufactured by M/s. Allergan Sales LLC, 2525 Dupont Drive,lrvine,CA 92612 |
2025-Sep-15 |
|
227 KB |
| 8 |
Stickering on Medical Products due to reduction in Goods Service Tax (GST) rate |
2025-Sep-11 |
|
86 KB |
| 9 |
Corrigendum to the letter dated 11.04.2025 on manufacturing and marketing of unapproved FDCs |
2025-Sep-10 |
|
433 KB |
| 10 |
Inviting comments on consideration of the proposal regarding problem faced by the blind or visually impaired people to read medicines tablets/capsules strips |
2025-Sep-09 |
|
714 KB |
